| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |